Global Vaccines & Vaccination Summit & B2B
November 01-02, 2017 | Toronto, Canada
Posters & Accepted Abstracts
-
A potent candidate black water fever malaria vaccine in the offing, Ugandan case
Ann Clin Trials Vaccines Res
Akusa Darlington -
Growing sustainable and resilient human vaccines development and manufacturing capabilities in Africa - challenges and opportunities
Ann Clin Trials Vaccines Res
Chidi V Nweneka, Patrick Tippoo, Ebrahim Mohamed and William Ampofo -
IFITM knockdown/knockout technology for vaccine production
Ann Clin Trials Vaccines Res
Mark Fife and Jon Moore -
Immunological studies on Tetanus Toxoid
Ann Clin Trials Vaccines Res
Rakesh Kumar -
Increased coverage of influenza and anti-pneumococcal vaccines in the integrated care management of Albacete
Ann Clin Trials Vaccines Res
Pedro J Tarraga Lopez, Antonio Naharro Manez, Francisco J Vadillo Olmo and Francisco Naharro de Mora -
Targeting conserved broadly neutralizing epitopes within HIV-1 envelope gp41 MPER as vaccine immunogens for seronegative partners of HIV-1 discordant couples
Ann Clin Trials Vaccines Res
Godwin W Nchinda